DLB 📈 Dolby Laboratories - Overview
Exchange: NYSE • Country: United States • Currency: USD • Type: Common Stock • ISIN: US25659T1079
DLB: Audio, Imaging, Codecs, Speakers, Amplifiers, Processors
Dolby Laboratories is a pioneer in the development of cutting-edge audio and imaging technologies, revolutionizing the entertainment experience across various platforms, including cinemas, digital television transmissions, mobile devices, over-the-top video and music services, home entertainment systems, and automobiles. The company's innovative solutions have been transforming the way people consume media, providing an immersive experience that engages audiences worldwide.
The company's portfolio of audio technologies is extensive, featuring a range of codecs and solutions that cater to diverse media applications. For instance, its AAC and HE-AAC codecs are widely used for digital audio compression, while the Dolby AC-4 technology delivers new audio experiences to various playback devices. Additionally, the company's Dolby Atmos technology has set a new standard for cinematic sound, providing an immersive experience that simulates the way we hear in real life. Other notable audio technologies include DD, DD+, and Dolby TrueHD, which provide multichannel sound, audio transmission, and encoding solutions for media applications.
Dolby Laboratories also develops and licenses imaging technologies, such as Dolby Vision, which enhances the visual experience for cinema and media devices. Furthermore, the company offers a range of digital video codecs, including AVC and HEVC, which provide high bandwidth efficiency for media devices. Its product lineup also includes digital cinema servers, cinema processors, amplifiers, loudspeakers, and audio and imaging hardware and software products, catering to the needs of the cinema, television, broadcast, communication, and entertainment industries.
In addition to its products, Dolby Laboratories provides a range of services, including 3-D glasses and kits, as well as support for theatrical and television production, cinema exhibition, broadcast, and home entertainment. The company's client base is diverse, comprising film studios, content creators, post-production facilities, cinema operators, broadcasters, and video game designers. With a global presence, Dolby Laboratories sells its products directly to end-users, as well as through dealers and distributors worldwide, ensuring that its innovative solutions reach a broad audience.
With a history spanning over five decades, Dolby Laboratories was founded in 1965 and is headquartered in San Francisco, California. The company's commitment to innovation and excellence has earned it a reputation as a leader in the entertainment technology industry. As a publicly traded company, Dolby Laboratories is listed on the New York Stock Exchange (NYSE) under the ticker symbol DLB, and its common stock is classified under the GICS Sub Industry of Electronic Components, with the ISIN code US25659T1079. For more information, visit the company's website at https://www.dolby.com
Additional Sources for DLB Stock
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
DLB Stock Overview
Market Cap in USD | 7,578m |
Sector | Industrials |
Industry | Specialty Business Services |
GiC Sub-Industry | Electronic Components |
IPO / Inception | 2005-02-17 |
DLB Stock Ratings
Growth 5y | 2.89% |
Fundamental | 58.6% |
Dividend | 56.8% |
Rel. Strength Industry | -134 |
Analysts | 4.67/5 |
Fair Price Momentum | 70.31 USD |
Fair Price DCF | 128.67 USD |
DLB Dividends
Dividend Yield 12m | 1.59% |
Yield on Cost 5y | 1.93% |
Annual Growth 5y | 7.04% |
Payout Consistency | 84.6% |
DLB Growth Ratios
Growth Correlation 3m | 50.5% |
Growth Correlation 12m | -67% |
Growth Correlation 5y | 15.5% |
CAGR 5y | 3.90% |
CAGR/Mean DD 5y | 0.24 |
Sharpe Ratio 12m | -0.41 |
Alpha | -31.12 |
Beta | 0.85 |
Volatility | 23.28% |
Current Volume | 1559.4k |
Average Volume 20d | 585.3k |
As of December 22, 2024, the stock is trading at USD 77.29 with a total of 1,559,418 shares traded.
Over the past week, the price has changed by -2.39%, over one month by -5.33%, over three months by +5.94% and over the past year by -8.44%.
Partly, yes. Based on ValueRay Fundamental Analyses, Dolby Laboratories (NYSE:DLB) is currently (December 2024) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 58.55 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of DLB as of December 2024 is 70.31. This means that DLB is currently overvalued and has a potential downside of -9.03%.
Dolby Laboratories has received a consensus analysts rating of 4.67. Therefor, it is recommend to buy DLB.
- Strong Buy: 2
- Buy: 1
- Hold: 0
- Sell: 0
- Strong Sell: 0
According to ValueRays Forecast Model, DLB Dolby Laboratories will be worth about 77.8 in December 2025. The stock is currently trading at 77.29. This means that the stock has a potential upside of +0.69%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | 100 | 29.4% |
Analysts Target Price | 98 | 26.8% |
ValueRay Target Price | 77.8 | 0.7% |